Skip to content

Construction of multimodal prediction system and traditional Chinese medicine intervention for adolescent depression based on the original syndrome differentiation theory of traditional Chinese medicine

Construction of multimodal prediction system and traditional Chinese medicine intervention for adolescent depression based on the original syndrome differentiation theory of traditional Chinese medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000162
Enrollment
Unknown
Registered
2024-08-04
Start date
2024-08-30
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressive disorder

Interventions

Experimental group:Shuyu powder and paroxetine hydrochloride tablets were taken orally
TCM control group:Shuyu powder and paroxetine hydrochloride simulated tablets were taken orally
The western medicine control group:paroxetine hydrochloride tablets and Chinese medicine free decoction granule placebo

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1) meet the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) Major Depressive disorder (MDD) Disorder), referring to "depression" and "anxiety disorder" in "TCM Treatment of Mental and Behavioral DiseasesInterpretation of will and Mind Syndrome Differentiation" (2008) and "depression disease" in "TCM Diagnostic Efficacy Criteria of Diseases and Syndromes" (2012), formulated the TCM diagnostic criteria of "insufficient spirit, depression of mind and soul". (2) The total score of the first 17 items of the 24 items of the Hamilton Depression Scale (HAMD) was =8 and =24; (3) age 12-18 years old, both sexes; (4) patients who were willing to be tested and signed informed consent; (5) had not taken antidepressant or anti-anxiety drugs in the past, or had taken but stopped the drugs for more than 1 month, beyond the drug washout period;

Exclusion criteria

Exclusion criteria: (1) patients with severe heart, liver or kidney dysfunction or complicated with other serious underlying diseases; (2) female patients during pregnancy or lactation; (3) patients with bipolar disorder and other psychotic disorders; (4) patients with previous allergies to the drugs used in the trial; (5) patients with long-term use of other psychotropic drugs.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale, HAMD-24;

Secondary

MeasureTime frame
blood routine examination;Nurses' Global Assessment of Suicide Risk scale;Non-Suicidal Self-Injury questionnaire;TCM syndrome quantitative table score;Somatic Selfrating Scale;liver function test;

Countries

China

Contacts

Public ContactZhaojun Yan

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

yzj7790@163.com13793188116

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026